Fabra, Pompeu

In Chapter 8, professor J.L. Pinto Prades of Pompeu Fabra University and X. Badla Llach of the Health Outcomes Research Unit at Santa Creu i Sant Pau Hospital take a look at the potential contribution of economic evaluation to the regulation and control of public spending on pharmaceuticals. The authors focus on observing how economic evaluation can be used in pharmaceutical policy. To this end, they distinguish and analyse the potential this instrument has in six distinct areas the approval of pharmaceuticals by health... [Pg.17]

In Chapter 9, lecturers V. Ortun Rubio of Pompeu Fabra University and L. Cabiedes Miragaya of the University of Oviedo address the subject of measures intended as a way of influencing prescriber decisions. The authors place special emphasis on analysing prescriber incentive policies, distinguishing between incentives of a financial nature (both coercive and non-coercive) and non-financial incentives (information, training, treatment protocols, monitoring of prescription practices, cost-effectiveness guidelines, interaction with other professionals, pressure from patients and so on). The authors advocate incentive policies based on a combination of financial and non-financial incentives. [Pg.18]

Danzon, P. (1998), Reference pricing theory and evidence , paper presented at the conference on the Effects of Reference Pricing of Medicines, 14-16 December, Universitat Pompeu Fabra, Barcelona. [Pg.122]

There have been recognized specialists in the subject for some years now. Recently we have witnessed the rise of organized specialist research units linked to universities. Examples are the Research Centre for Economics and Health (CRES) at Pompeu Fabra University and the Health and Pharmaceuticals Social Studies Seminar at Carlos III University in Madrid. [Pg.212]

Research Centre for Economics and Health (CRES), Department of Economics and Business, Pompeu Fabra University, Spain... [Pg.261]

Pompeu Fabra University GRIB-IMIM Dr Aiguader 80 E080003 Barcelona Spain... [Pg.502]

Maria-Isabel Covas, Research Unit on Lipids and Cardiovascular Epidemiology, Institut Municipal d lnvestigacio Medica (IMIM). Universitat Pompeu Fabra (CEXS-UPF), Barcelona, Spain... [Pg.425]

Chemogenomics Laboratory, Research Unit on Biomedical Informatics, Municipal Institute of Medical Research and University Pompeu Fabra, Dr. Aiguadev 88, 08003 Barcelona, Catalonia, Spain. Email jmestres imim.es. [Pg.39]

Prof. Jordi Mestres from the Chemogenomics Laboratory at the University Pompeu Fabra in Barcelona summarizes in Chapter 2 mapping methodologies of the chemogenomics space and provides herewith an essential prerequisite for extracting knowledge from biochemical data. [Pg.215]

Institut Munidpal d lnvestigacio Medica and Universitat Pompeu Fabra Chemotargets SL and Chemogenomics Laboratory... [Pg.515]

Universitat Pompeu Fabra Systems Pharmacology Research Program on Biomedical Informatics... [Pg.442]

The Spectrum Modelling Synthesis system (SMS) developed by Xavier Serra, of Pompeu Fabra University, in Barcelona, Spain, is an edifying example of resynthesis by reintegration... [Pg.64]

St.Anna School of Advanced Studies and Universitat Pompeu Fabra-CREA... [Pg.3]

Arora A., Gambardella A. and Garcia-Fontes W., 1998, Investment Flows of Large Chemical Companies , University Pompeu Fabra , Barcelona (Spain), mimeo. [Pg.23]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...